Announcements and Notices - [Inside Information / Quarterly Results / Overseas Regulatory Announcement - Trading Update / Other - Miscellaneous]

InnoCare Pharma Limited researches, develops, manufactures, and distributes pharmaceuticals. The Company produces antibiotic drugs, respiratory drugs, cardiovascular drugs, vitamin tablets, health care drugs, and other related products. InnoCare Pharma markets its products throughout China.

2024 Quarterly Report For The Third Quarter
And Update In Use Of Proceeds

Announcements and Notices - [Date of Board Meeting]

Date Of Board Meeting

Announcements and Notices - [Other - Business Update]

Voluntary Announcement - Phase Ii Clinical Study Of Icp-488 For The Treatment Of
Moderate-To-Severe Plaque Psoriasis Met Primary
Endpoint

Announcements and Notices - [List of Directors and their Role and Function]

List Of Directors And Their Roles And Functions

Announcements and Notices - [Change in Directors or of Important Executive Functions or Responsibilities / Change of Audit Committee Member / Change of Remuneration Committee Member / Non-compliance with INED Requirements or INED Failing to Meet Independence Guidelines]

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

InnoCare Pharma Ltd (9969 HK)

2024 Quarterly Report For The Third Quarter And Update In Use Of Proceeds

Date Of Board Meeting

Voluntary Announcement - Phase Ii Clinical Study Of Icp-488 For The Treatment Of Moderate-To-Severe Plaque Psoriasis Met Primary Endpoint

List Of Directors And Their Roles And Functions

(1) Resignation Of Non-Executive Director (2) Resignation Of Independent Non-Executive Director And (3) Change In Composition Of Board Committees

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)